These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 28884732)

  • 41. Patients with chronic obstructive pulmonary disease have shorter survival but superior endovascular outcomes after endovascular aneurysm repair.
    Qureshi MA; Greenberg RK; Mastracci TM; Eagleton MJ; Hernandez AV
    J Vasc Surg; 2012 Oct; 56(4):911-9.e2. PubMed ID: 23026421
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of restrictive versus obstructive pulmonary function patterns on mortality in patients undergoing transcatheter aortic valve implantation.
    Escárcega RO; Torguson R; Tavil-Shatelyan A; Daoud Y; Koifman E; Kiramijyan S; Gai J; Satler LF; Pichard AD; Waksman R
    Cardiovasc Revasc Med; 2016; 17(3):181-5. PubMed ID: 26997471
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of periodontal treatment on lung function and exacerbation frequency in patients with chronic obstructive pulmonary disease and chronic periodontitis: a 2-year pilot randomized controlled trial.
    Zhou X; Han J; Liu Z; Song Y; Wang Z; Sun Z
    J Clin Periodontol; 2014 Jun; 41(6):564-72. PubMed ID: 24593836
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Interleukin-17 expression and significance in normal lung function smokers and chronic obstructive pulmonary disease patients].
    Zhang JQ; Lao QF; Chu SY; Bai J; Zhong XN
    Zhonghua Yi Xue Za Zhi; 2010 May; 90(20):1431-5. PubMed ID: 20646637
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Condition of hemodynamics in the pulmonary circulation of patients with chronic obstructive pulmonary disease (copd) concurrent with metabolic syndrome with hypertrophy and atrophy of the myocardium.
    Boriak VP; Shut SV; Trybrat TA; Filatova OV
    Wiad Lek; 2019 Aug; 72(8):1491-1493. PubMed ID: 32003202
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical, physiological, and radiological features of asthma-chronic obstructive pulmonary disease overlap syndrome.
    Suzuki T; Tada Y; Kawata N; Matsuura Y; Ikari J; Kasahara Y; Tatsumi K
    Int J Chron Obstruct Pulmon Dis; 2015; 10():947-54. PubMed ID: 26028967
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Changes in the endurance shuttle walk test in COPD patients with chronic respiratory failure after pulmonary rehabilitation: the minimal important difference obtained with anchor- and distribution-based method.
    Altenburg WA; Duiverman ML; Ten Hacken NH; Kerstjens HA; de Greef MH; Wijkstra PJ; Wempe JB
    Respir Res; 2015 Feb; 16(1):27. PubMed ID: 25849109
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The influence of selective pulmonary perfusion on the inflammatory response and clinical outcome of patients with chronic obstructive pulmonary disease undergoing cardiopulmonary bypass.
    Kiessling AH; Guo FW; Gökdemir Y; Thudt M; Reyher C; Scherer M; Beiras-Fernandez A; Moritz A
    Interact Cardiovasc Thorac Surg; 2014 Jun; 18(6):732-9. PubMed ID: 24632426
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy and tolerability of indacaterol 75 μg once daily in patients aged ≥40 years with chronic obstructive pulmonary disease: results from 2 double-blind, placebo-controlled 12-week studies.
    Kerwin EM; Gotfried MH; Lawrence D; Lassen C; Kramer B
    Clin Ther; 2011 Dec; 33(12):1974-84. PubMed ID: 22177371
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevalence of thoracic pain in patients with chronic obstructive pulmonary disease and relationship with patient characteristics: a cross-sectional observational study.
    Janssen DJ; Wouters EF; Parra YL; Stakenborg K; Franssen FM
    BMC Pulm Med; 2016 Apr; 16():47. PubMed ID: 27052199
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Assessment of pulmonary rehabilitation efficacy in chronic obstructive pulmonary disease patients using the chronic obstructive pulmonary disease assessment test.
    Candemir I; Kaymaz D; Ergun P; Demir N; Egesel N; Sengul F
    Expert Rev Respir Med; 2015 Aug; 9(4):487-92. PubMed ID: 26160067
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Severe pulmonary hypertension associated with COPD: hemodynamic improvement with specific therapy.
    Girard A; Jouneau S; Chabanne C; Khouatra C; Lannes M; Traclet J; Turquier S; Delaval P; Cordier JF; Cottin V
    Respiration; 2015; 90(3):220-8. PubMed ID: 26277885
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prevalence of comorbidities according to predominant phenotype and severity of chronic obstructive pulmonary disease.
    Camiciottoli G; Bigazzi F; Magni C; Bonti V; Diciotti S; Bartolucci M; Mascalchi M; Pistolesi M
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2229-2236. PubMed ID: 27695310
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [The role of interval hypoxytherapy and enteral oxygen therapy in the rehabilitation of the patients presenting with chronic obstructive pulmonary disease].
    Borukaeva IK; Abazova ZK; Ivanov AB; Shkhagumov KY
    Vopr Kurortol Fizioter Lech Fiz Kult; 2019; 96(2):27-32. PubMed ID: 31095126
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [On the assessment of medical rehabilitation effectiveness in patients with chronic obstructive pulmonary disease in the resort setting].
    Zaripova TN; Dorozhinskaya EV; Titskaya EV; Reshetova GG
    Vopr Kurortol Fizioter Lech Fiz Kult; 2022; 99(1):20-27. PubMed ID: 35236062
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Analysis of diaphragmatic movement before and after pulmonary rehabilitation using fluoroscopy imaging in patients with COPD.
    Chun EM; Han SJ; Modi HN
    Int J Chron Obstruct Pulmon Dis; 2015; 10():193-9. PubMed ID: 25670895
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Classification of patients with chronic obstructive pulmonary disease according to the Latin American Thoracic Association (ALAT) staging systems and the global initiative for chronic obstructive pulmonary disease (GOLD).
    Montes de Oca M; López Varela MV; Laucho-Contreras ME; Casas A; Schiavi E; Rey A; Silva A;
    Arch Bronconeumol; 2017 Mar; 53(3):98-106. PubMed ID: 27956034
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Anti-inflammatory effects of atorvastatin treatment in chronic obstructive pulmonary disease. A controlled pilot study.
    Mroz RM; Lisowski P; Tycinska A; Bierla J; Trzeciak PZ; Minarowski L; Milewski R; Lisowska A; Boros P; Sobkowicz B; Duszewska AM; Chyczewska E; Musial WJ; MacNee W
    J Physiol Pharmacol; 2015 Feb; 66(1):111-28. PubMed ID: 25716971
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A randomized multicenter Phase II study of perioperative tiotropium intervention in gastric cancer patients with chronic obstructive pulmonary disease.
    Fushida S; Oyama K; Kaji M; Hirono Y; Kinoshita J; Tsukada T; Nezuka H; Nakano T; Noto M; Nishijima K; Fujimura T; Ohta T
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2177-83. PubMed ID: 26491284
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Peak expiratory flow rate as a surrogate for forced expiratory volume in 1 second in COPD severity classification in Thailand.
    Pothirat C; Chaiwong W; Phetsuk N; Liwsrisakun C; Bumroongkit C; Deesomchok A; Theerakittikul T; Limsukon A
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1213-8. PubMed ID: 26150713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.